Corporate GovernanceMay 20, 2026, 04:18 PM
Adicet Bio Amends 10-K to Update Controls & Procedures Disclosure
AI Summary
Adicet Bio, Inc. filed an amended Annual Report on Form 10-K/A for the year ended December 31, 2025. This amendment corrects an inadvertent omission in Item 9A "Controls and Procedures" from the original filing. The updated disclosure now includes statements from the company's principal executive and financial officers, confirming that disclosure controls and procedures, as well as internal control over financial reporting, were effective as of December 31, 2025.
Key Highlights
- Adicet Bio filed Form 10-K/A to amend its Annual Report for December 31, 2025.
- The amendment corrects an omission in Item 9A "Controls and Procedures."
- Principal executive and financial officers concluded disclosure controls and procedures were effective as of December 31, 2025.
- Management concluded internal control over financial reporting was effective as of December 31, 2025.
- No material changes in internal control over financial reporting occurred during 2025, aside from a prior remediation plan.
Price Impact
More from ACET